Raxibacumab, medically designated as PAmAb ABthrax, represents a groundbreaking medication approach for the infection. This single immunoglobulin , designed by ProBioGen AG , specifically targets the https://raxibacumabmab609340.blogdigy.com/raxibacumab-a-in-depth-exploration-into-the-p-antim-abab-anthrax-69734957